Attitudes about genetic testing for breast-ovarian cancer susceptibility

Journal of Clinical Oncology

Volumn 12, Issue 4, 1994, Pages 843-850

  Lerman, Caryn ^a   Daly, Mary ^b   Masny, Agnes ^b   Balshem, Andrew ^b  

^a GEORGETOWN UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; FEMALE; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; HUMAN; OVARY CANCER; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; RELATIVE;

EID: 0028208432     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1994.12.4.843     Document Type: Article

References (38)

1. Lynch HT, Albano WA, Heieck JJ, et al: Genetics, biomarkers, and control of breast cancer: A review. Cancer Genet Cytogenet 13:43-92, 1984
2. Hall JM, Friedman L, Guenther C, et al: Closing in on a breast cancer gene on chromosome 17q. Am J Hum Genet 50:1235-1242, 1992
3. Easton DF, Bishop DT, Ford D, et al: Genetic linkage analysis in familial breast and ovarian cancer: Results from 214 families. Am J Hum Genet 52:678-701, 1993
4. Narod SA, Feunteun J, Lynch HT, et al: Familial breast-ovarian cancer locus on chromosome 17q12-q23. Lancet 338:82-83, 1991
5. Feunteun J, Narod SA, Lynch HT, et al: A breast-ovarian cancer susceptibility gene maps to chromosome 17q21. Am J Hum Genet 52:736-742, 1993
6. Biesecker BB, Boehnke M, Calzone K, et al: Genetic counseling for families with inherited susceptibility to breast and ovarian cancer. JAMA 269:1970-1974, 1993
7. Lynch HT, Watson P, Conway TA, et al: DNA screening for breast/ovarian cancer susceptibility based on linked markers: A family study. Arch Intern Med 153:1979-1987, 1993
8. King MC, Rowell S, Love SM: Inherited breast and ovarian cancer: What are the risks? What are the choices? JAMA 269:1975-1980, 1993
9. Claus EB, Risch NJ, Thompson WD: Genetic analysis of breast cancer in the cancer and steroid hormone study. Am J Hum Genet 48:232-242, 1991
10. Craufurd D, Dodge A, Kerzin-Storrar L, et al: Uptake of presymptomatic predictive testing for Huntington's disease. Lancet 2:603-605, 1989
11. Lerman C, Rimer BK, Engstrom PF: Cancer risk notification: Psychosocial and ethical implications. J Clin Oncol 9:1275-1282, 1991
12. Li FP, Fraumeni JF Jr: Predictive testing for inherited mutations in cancer-susceptibility genes. J Clin Oncol 10:1203-1204, 1992
13. Becker MH (ed): The Health Belief Model and personal health behavior. Health Educ Monogr 2:45-50, 1974
14. Croyle RT, Lerman C: Interest in genetic testing for colon cancer susceptibility: Cognitive and emotional correlates. Prev Med 22:284-292, 1993
15. Becker MH, Kaback MM, Rosenstock IM, et al: Some influences on public participation in a genetic screening program. J Commun Health 1:3-14, 1975
16. Miller SM: When is a little knowledge a dangerous thing? Coping with stressful events by monitoring versus blunting, in Levine S, Ursin H (eds): Coping and Health: Proceedings of a NATO Conference. New York, NY, Plenum, 1980, pp 145-169
17. Lerman C, Trock B, Rimer BK, et al: Psychological and behavioral implications of abnormal mammograms. Ann Intern Med 114:657-661, 1991
18. Lerman C, Daly M, Sands C, et al: Mammography adherence and psychological distress among women at risk for breast cancer. J Natl Cancer Inst 85:1074-1080, 1993
19. Miller SM, Mangan CE: Interacting effects of information and coping style in adapting to gynecologic stress: Should the doctor tell all? J Pers Soc Psychol 45:223-236, 1983
20. McNair DM, Lorr M, Droppleman LF: Profile of Mood States Manual. San Diego, CA, Educational & Industrial Testing Service, 1971
21. Markel DS, Young AB, Penney JB: At-risk persons' attitudes toward presymptomatic and prenatal testing of Huntington disease in Michigan. Am J Med Genet 26:295-305, 1987
22. Mastromauro C, Myers RH, Berkman B: Attitudes toward presymptomatic testing in Huntington disease. Am J Med Genet 26:271-282, 1987
23. Ganz PA, Schag AC, Lee JJ, et al: Breast conservation versus mastectomy: Is there a difference in psychological adjustment or quality of life in the year after surgery? Cancer 69:1729-1738, 1992
24. Stanton AL, Snider PR: Coping with a breast cancer diagnosis: A prospective study. Health Psychol 12:16-23, 1993
25. Lerman C, Daly M, Walsh W, et al: Communication between patients with breast cancer and health care providers: Determinants and implications. Cancer 72:2612-2620, 1993
26. Daly M, Lerman C: Ovarian cancer risk counseling. Oncology (in press)
27. Croyle RT, Lerman C: Psychological impact of genetic testing, in Croyle RT (ed): Psychosocial Effects of Screening for Disease Prevention and Detection. New York, NY, Oxford University, 1993, pp 1-33
28. Bloch M, Fahy M, Fox S, et al: Predictive testing for Huntington disease: II. Demographic characteristics, life-style patterns, attitudes, and psychosocial assessments of the first fifty-one test candidates. Am J Med Genet 32:217-224, 1989
29. Tobacman JK, Greene MH, Tucker MA, et al: Intra-abdominal carcinomatosis after prophylactic oophorectomy in ovarian cancer-prone families. Lancet 2:795-797, 1982
30. Danforth DN Jr: Prophylactic mastectomy to prevent cancer of the breast in high-risk patients, in DeVita VT Jr, Hellman S, Rosenberg SA (eds): Cancer Prevention. Philadelphia, PA, Lippincott, 1990, pp 1-12
31. Miller AB, Baines CJ, To T, et al: Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years. Can Med Assoc J 147:1477-1488, 1992
32. Creasman WT, DiSaia PJ: Screening in ovarian cancer. Am J Obstet Gynecol 165:7-10, 1991
33. Lerman C, Schwartz M: Adjustment and adherence in women at high risk for breast cancer. Breast Cancer Res Treat (in press)
34. Lerman C, Croyle B: Psychological issues in genetic testing for breast cancer susceptibility. Arch Intern Med (in press)
35. Kash KM, Holland JC, Halper MS, et al: Psychological distress and surveillance behaviors of women with a family history of breast cancer. J Natl Cancer Inst 84:24-30, 1992
36. Wiggins S, Whyte P, Huggins M, et al: The psychological consequences of predictive testing for Huntington's disease. N Engl J Med 327:1401-1405, 1992
37. Nance MA, Leroy BS, Orr HT, et al: Protocol for genetic testing in Huntington disease: Three years of experience in Minnesota. Am J Med Genet 40:518-522, 1991
38. Ajzen I, Fishbein M: Understanding Attitudes and Predicting Social Behavior. Englewood Cliffs, NJ, Prentice-Hall, 1980